A new piece in the puzzle: the eosinophil and the development of COPD

Nayia Petousi, Abigail Wooden, Richard E.K. Russell

Source: Eur Respir J, 58 (4) 2101105; 10.1183/13993003.01105-2021

Journal Issue: October

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nayia Petousi, Abigail Wooden, Richard E.K. Russell. A new piece in the puzzle: the eosinophil and the development of COPD. Eur Respir J, 58 (4) 2101105; 10.1183/13993003.01105-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Targeting neutrophils in asthma: a strategy shared with COPD? Source: Annual Congress 2012 - Are neutrophils a suitable target in severe asthma? Year: 2012
Wood smoke COPD: a new description of a COPD phenotype? Source: Eur Respir J 2014; 44: 262-263 Year: 2014
Wood smoke COPD: a new description of a COPD phenotype? Source: Eur Respir J 2014; 44: 261-262 Year: 2014
Towards the next stage of novel biomarker discussion in COPD: Tekizai-Tekisho Source: Eur Respir J 2014; 43: 322-324 Year: 2013
The pathogenesis of IPF: what is the latest paradigm? Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis Year: 2019
The challenge of getting the right diagnosis: asthma and COPD, new diagnostic possibilities Source: International Congress 2016 – Primary Care Day: challenging times I Year: 2016
The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases? Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010
NORDSTAR: paving the way for a new era in asthma research Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019 Year: 2020
COPD exacerbations: is eosinophilia a protective factor? Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
T-cell biology and eosinophils in asthma: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019
The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013